These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38995799)

  • 1. Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms.
    König A; Outeiro TF
    J Parkinsons Dis; 2024; 14(5):917-924. PubMed ID: 38995799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 4. Unveiling new secrets in Parkinson's disease: The glycatome.
    Chegão A; Vicente Miranda H
    Behav Brain Res; 2023 Mar; 442():114309. PubMed ID: 36706808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.
    Biosa A; Outeiro TF; Bubacco L; Bisaglia M
    Mol Neurobiol; 2018 Nov; 55(11):8754-8763. PubMed ID: 29594935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies.
    Schildknecht S; Gerding HR; Karreman C; Drescher M; Lashuel HA; Outeiro TF; Di Monte DA; Leist M
    J Neurochem; 2013 May; 125(4):491-511. PubMed ID: 23452040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.
    Xie B; Lin F; Ullah K; Peng L; Ding W; Dai R; Qing H; Deng Y
    Biochem Biophys Res Commun; 2015 Apr; 459(3):361-6. PubMed ID: 25744031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interplay Between Proteostasis Systems and Parkinson's Disease.
    Lázaro DF; Outeiro TF
    Adv Exp Med Biol; 2020; 1233():223-236. PubMed ID: 32274759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes mellitus augments Parkinson's disease risk or the other way around: Facts, challenges and future possibilities.
    Faizan M; Sarkar A; Singh MP
    Ageing Res Rev; 2022 Nov; 81():101727. PubMed ID: 36038113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes.
    Chegão A; Guarda M; Alexandre BM; Shvachiy L; Temido-Ferreira M; Marques-Morgado I; Fernandes Gomes B; Matthiesen R; Lopes LV; Florindo PR; Gomes RA; Gomes-Alves P; Coelho JE; Outeiro TF; Vicente Miranda H
    NPJ Parkinsons Dis; 2022 Apr; 8(1):51. PubMed ID: 35468899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes (T2DM) and Parkinson's Disease (PD): a Mechanistic Approach.
    Sabari SS; Balasubramani K; Iyer M; Sureshbabu HW; Venkatesan D; Gopalakrishnan AV; Narayanaswamy A; Senthil Kumar N; Vellingiri B
    Mol Neurobiol; 2023 Aug; 60(8):4547-4573. PubMed ID: 37118323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein-induced stress sensitivity renders the Parkinson's disease brain susceptible to neurodegeneration.
    Nakos Bimpos M; Karali K; Antoniou C; Palermos D; Fouka M; Delis A; Tzieras I; Chrousos GP; Koutmani Y; Stefanis L; Polissidis A
    Acta Neuropathol Commun; 2024 Jun; 12(1):100. PubMed ID: 38886854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.
    König A; Vicente Miranda H; Outeiro TF
    J Parkinsons Dis; 2018; 8(1):33-43. PubMed ID: 29480231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
    J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycation in Parkinson's disease and Alzheimer's disease.
    Vicente Miranda H; El-Agnaf OM; Outeiro TF
    Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico analysis of alpha-synuclein protein variants and posttranslational modifications related to Parkinson's disease.
    da Silva ANR; Pereira GRC; Bonet LFS; Outeiro TF; De Mesquita JF
    J Cell Biochem; 2024 Mar; 125(3):e30523. PubMed ID: 38239037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.
    Subramaniam SR; Vergnes L; Franich NR; Reue K; Chesselet MF
    Neurobiol Dis; 2014 Oct; 70():204-13. PubMed ID: 25016198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.
    Wang W; Nguyen LT; Burlak C; Chegini F; Guo F; Chataway T; Ju S; Fisher OS; Miller DW; Datta D; Wu F; Wu CX; Landeru A; Wells JA; Cookson MR; Boxer MB; Thomas CJ; Gai WP; Ringe D; Petsko GA; Hoang QQ
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9587-92. PubMed ID: 27482083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.
    Sohrabi T; Mirzaei-Behbahani B; Zadali R; Pirhaghi M; Morozova-Roche LA; Meratan AA
    J Mol Biol; 2023 Jun; 435(12):167992. PubMed ID: 36736886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.